Miramar Capital, LLC Omeros Corp Transaction History

Miramar Capital, LLC

  • $400 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021
SELL
$14.81 - $19.13 $174,980 - $226,020
-11,815 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$10.14 - $15.19 $119,804 - $179,469
11,815 New
11,815 $256,000
Q2 2019

Aug 08, 2019
SELL
$15.0 - $19.62 $213,750 - $279,585
-14,250 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$10.72 - $16.73 $152,760 - $238,402
14,250 New
14,250 $192,000

Others Institutions Holding OMER

# of Institutions
113
Shares Held
25.5M
Call Options Held
317K
Put Options Held
556K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $256M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Miramar Capital, LLC Portfolio

Follow Miramar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miramar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miramar Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email